Back to mobile site

Jefferies Reiterates Hold Rating on Aurinia Pharmaceuticals (AUPH)

September 30, 2025 2:37 AM EDT Send to a Friend
Jefferies analyst Maury Raycroft reiterated a Hold rating and $10.00 price target on Aurinia Pharmaceuticals (NASDAQ: AUPH)The analyst comments: "In ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login